1,328
Views
20
CrossRef citations to date
0
Altmetric
Review

Transcranial magnetic stimulation for the treatment of cocaine addiction: evidence to date

, , &
Pages 11-21 | Published online: 21 May 2018

Abstract

There is a common consensus in considering substance-use disorders (SUDs) a devastating chronic illness with social and psychological impact. Despite significant progress in understanding the neurobiology of SUDs, therapeutic advances have proceeded at a slower pace, in particular for cocaine-use disorder (CUD). Transcranial magnetic stimulation (TMS) is gaining support as a safe and cost-effective tool in the treatment of SUDs. In this review, we consider human studies that have investigated the efficacy of TMS in achieving therapeutic benefits in treating CUD. All studies conducted to date that have evaluated the therapeutic effect of TMS in CUD are included. We focus on the protocol of stimulation applied, emphasizing the neurophysiological effects of coils employed related to outcomes. Moreover, we examine the subjective and objective measurements used to assess the therapeutic effects along the timeline considered. The revision of scientific literatures underscores the therapeutic potential of TMS in treating CUD. However, the variability in stimulation protocols applied and the lack of methodological control do not allow us to draw firm conclusions, and further studies are warranted to examine the interaction between TMS patterns of stimulation relative to clinical outcomes in depth.

Introduction

The annual overview of the European drug situation highlighted that substance-use disorders (SUDs; ie, cannabis, cocaine, MDMA, amphetamines, opioids) represent a major public health concern in the Western world, with about 24.3 million young adult users (aged 15–34 years) in 2017.Citation1 SUDs can be described as a chronic neuropathology characterized by a reduction in the ability to control compulsive drug-seeking behavior, regardless of negative consequences.Citation2 Preclinical studies in rodents and human imaging evidence have shown the role of repetitive drug use in aberrant forms of neural plasticity consisting, briefly, in a significant reduction in dopaminergic activity linked to the dysfunction of cortical and subcortical pathways.Citation3Citation21 These findings complement the fundamental building blocks of the dopamine (DA) hypothesis of drug addiction, which ascribes to the hypofunctioning DA system a key role in the genesis of drug abuse and leads to the theory that functional “boosting” of DA signaling may hold beneficial effects in reducing drug craving/intake.Citation4,Citation22,Citation23

Drug addiction is now considered a whole-brain pathology, since brain-wide activity patterns are compromised.Citation18,Citation19,Citation24,Citation25 These changes in brain function lead to the motivational and cognitive impairment that characterizes addictive disorders.Citation10,Citation13,Citation26 Indeed, alterations in mesocortical brain networks and related dysfunction in dopaminergic activity are accompanied by increased salience for the abused substance and increased cue reactivity for related stimuli, which in turn support the motivation/drive to use the substance and to relapse.Citation27Citation30 This mechanism seems to have a putative role in the development of addiction, amplified and supported by an uncontrollable urge to take the substance of abuse (ie, craving), which leads to searching for the substance and relapse. Indeed, higher craving rates are related to higher relapse rates.Citation18,Citation19,Citation31,Citation32 Despite the fact that drug craving is considered an important risk factor for relapse, it can be counteracted and restricted by exerting cognitive and behavioral control.Citation33,Citation34 However, the diminished functioning of the dorsolateral prefrontal cortex (DlPfCx) and anterior cingulate cortex provides a reason for the impaired inhibitory behavioral control and higher tendency to relapse in alcohol and/or drug use.Citation34Citation38

However, despite these recent advances in understanding the neurobiology of addiction, expectations of therapeutic treatments have fallen shorter than desired.Citation39,Citation40 Transcranial magnetic stimulation (TMS) represents a nonpharmacological tool and a testable opportunity in the treatment of SUDs, owing to its capacity to target and modulate specific brain circuits that are involved in the neuropathology of addiction.Citation41Citation44

Therefore, we searched among published studies that investigated the efficacy of TMS in the treatment of SUDs and focused on those applied to cocaine addicts. Papers were identified through NCBI PubMed research by using “TMS”, “addiction”, and “cocaine” as keywords. Among published studies, only six focused on the treatment of cocaine addiction. These are reviewed in the present paper, with particular reference to the stimulation protocol applied and outcome observed.

TMS physiology

Since 1985, when TMS was implemented for the first time in the study of motor-cortex excitability, the potential therapeutic effect of brain stimulation is being investigated in different psychiatric disorders, such as major depression, obsessive–compulsive disorders, schizophrenia, and addictive disorders.Citation41,Citation43Citation50 TMS can be described as a nonsurgical brain stimulation that is able to modulate cortical excitability through magnetic fields inducted over the scalp.Citation51 The passage of electric current in the coil induces a transient, high-intensity magnetic pulse that penetrates the scalp and reaches the neurons of the targeted cortical area painlessly in the conscious subject. Generally, 1 Hz frequency (or below) of consecutive stimuli, ie, repetitive TMS (rTMS), inhibits cortical excitability, whereas high frequency (5–20 Hz) produces increased cortical excitability.Citation43,Citation44 This change in cortical activity is able to produce both physiologic and behavioral effects, depending on the parameters of stimulation applied.Citation52Citation54 The total duration of the session, the frequency of stimulation employed, the intensity (relative to motor threshold [MT]), and pattern of stimulation are the key factors in determining long-lasting TMS effects, since physiological and behavioral effects are mediated by the traditional phenomena of Hebbian synaptic plasticity, consisting in long-term potentiation (LTP) and long-term depression (LTD) of neuronal activity.Citation44,Citation55,Citation56 Despite variability in the protocol of stimulation applied, a number of studies (Table S1) have shown efficacy of TMS in reducing craving and consumption in alcoholics and nicotine-dependent subjects. Additional recent work highlights the therapeutic potential of rTMS in cue-induced craving for methamphetamine, heroin-cue craving, and food craving.Citation57Citation65

These findings suggest that rTMS modulates neural activity via two main mechanisms: through the frontostriatal glutamate-bearing afferents to medium spiny neurons of the ventral striatum, and projections from pyramidal neurons of the fifth layer of the PfCx impinging upon DA-containing midbrain neurons, thereby inducing DA release in the nucleus accumbens.Citation11,Citation22,Citation66,Citation67

The effect of TMS to increase DA levels transiently in cortical areas and its ability to modulate reduced dopaminergic activity in the limbic system appears to be among the mechanisms in restoring predrug functionality at a system level.Citation44 On the other hand, by stimulating the PfCx, functioning of the cortical network can be strengthened and hopefully improve executive-control circuits.Citation7,Citation9,Citation35,Citation68

Key TMS factors

At present, the need to find the best stimulation parameters to optimize the clinical outcome is the main target. Recent studies have pointed out the importance of the characteristics of the magnetic E-field inducted in association with the clinical outcome, theorizing that a deeper stimulation may have more chance of reaching dysfunctional brain areas, and through this “direct way” better odds of obtaining long-lasting effects, such as reduction in craving and drug consumption.Citation69Citation71

The activation of targeted brain areas depends on the shape of the magnetic E-field, spatial accuracy, and penetration depth of stimulation.Citation72 These factors are dictated by coil geometry, which then defines the capability of stimulation to activate the brain areas of interest aimed at restoring the dysfunctional neuronal network, eventually. Considering that the intensity of the E-field is maximal closest to the coil, stimulation intensity is strongest over the brain surface and rapidly attenuates with distance.Citation73 The most widely used coil implemented in the study of TMS effects is the figure-of-eight coil, which owing to its geometry (figure of eight), is able to project focal fields over the brain surface with high spatial resolution (2.5–3 cm2).Citation74 However, the E-fields remain quite superficial and tend to dissipate in intensity rapidly, with little chance of reaching deeper brain areas disrupted by the neuropathology of addiction.Citation73 Moreover, discrepancies in the geometry of magnetic fields generated by the figure-of-eight coil and thus in the localization of the area targeted may account for the variability in effects observed.

In 2002, Roth et al designed a new coil called a Hesed-coil (H-coil) able to stimulate the PfCx bilaterally and through the stimulation of frontostriatal projections activate midbrain DA neurons and other subcortical areas involved in dopaminergic activity, at least in theory.Citation69,Citation75 Recently, Malik et al tested the capacity of the H-coil to modulate DA release in eight healthy subjects, finding that low-frequency rTMS (1 Hz) significantly decreased DA levels in the substantia nigra and sensorimotor and associative striata.Citation76 This novel coil seems to have more chance of obtaining consistent and prolonged effects, presumably due to its ability to stimulate subcortical brain regions that are involved in the development of addiction’s neuropathology. However, since cortical thickness is contained within 2 cm from the skin surface, targeting fifth-layer cortical pyramidal neurons (efferent) may suffice to modulate subcortical circuitries involved in taking and relapse.Citation22,Citation44,Citation77

If the coil geometry is among the key factors in the efficacy of stimulation to activate the targeted brain areas, anatomical pathways also play an important role in the final effect of stimulation.Citation53,Citation72 For this reason, the TMS navigator device integrated with a magnetic resonance imaging guide was developed, which is able to identify the targeted area to stimulate and to estimate the orientation, intensity, and gradients of the E-fields based on the subject’s brain anatomy.Citation78 This innovative integrated approach of TMS plus neuronavigation will be useful in future to optimize the TMS effect and by that to ameliorate clinical benefits.

TMS for treatment of cocaine addiction: evidence to date

The six studies that investigated the effect of TMS in cocaine addiction are discussed herein and summarized in . In 2007, Camprodon et al investigated the effect of rTMS on cocaine craving. Secondary end points were changes in anxiety, happiness, sadness, and discomfort.Citation79 In this randomized crossover study, six patients fulfilling Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM)-IV criteria for cocaine dependence underwent two session of rTMS – one to the left and one to the right DlP-fCx – with a week’s break between sessions. Patients were asked to complete a visual analog scale (VAS) ranging from “not at all” to “more than ever” before, immediately after, and 4 hours after TMS. Notably, during the whole study, patients remained hospitalized. The protocol of stimulation consisted in two sessions of stimulation (right/left) with 20 trains each of 10-second length and 1 second of interstimulus for a total of 2,000 pulses. The frequency of stimulation was 10 Hz, while the intensity was 90% of the individual’s MT. The authors found a transient effect of one session of 10Hz rTMS over the right DlPfCx, but not the left, which consisted in a (statistically) significant reduction in craving for cocaine. A significant difference in “desire to consume cocaine” was found between baseline and post-TMS ratings craving and between post-TMS and 4 hours post-TMS, but no significant difference was found between pre-TMS and 4 hours later. Despite the TMS effect resolving in 4 hours after stimulation, this research provided the first evidence that one session of high-intensity rTMS over the right DlPfCx transiently reduce craving in chronic cocaine abusers.Citation79,Citation80 Following this preliminary study, Politi et al explored the potential of rTMS in reducing cocaine craving by applying it over the left DlPfCx for ten daily sessions. High-frequency (15 Hz) rTMS was administered over the left DlPfCx of 36 cocaine addicts.Citation81 The stimulation consisted of 20 trains of rTMS at 100% subjective MT for a total of 600 pulses. No control group was considered in this experiment. As in the previous study, the researchers assessed the TMS effects through the VAS, and found a reduction in craving level. Although different in the paradigm applied, these two studies suggest that rTMS reduces cocaine craving. Moreover, they demonstrated the central role of DlPfCx in modulating craving, as suggested earlier by imaging studies.Citation82Citation84

Table 1 Studies that have implemented TMS in the treatment of cocaine addicts

Terraneo et al studied the effects of rTMS on cocaine intake by applying it over the left DlPfCx.Citation85 The authors assessed the rTMS effect with an objective marker of cocaine consumption. The primary outcome of the study was the use of cocaine assessed by urine drug screen. Secondary outcomes were cocaine craving and depressive symptoms. Unlike previous studies, the authors described the stimulator device used and the procedure to obtain subjective MT. They employed a figure-of-eight coil (as per Camprodon et al and Politi et al) to deliver the treatment, which consisted of eight sessions of rTMS delivered at 15 Hz and 100% MT, 60 pulses per train, and 40 stimulation trains, with 15 seconds of inter-stimulus interval for a total of 2,400 pulses. They used a TMS Navigator. This approach allows the experimenter to have higher methodological control. The experiment was designed in two stages, and included a control group treated with a routine pharmacological protocol consisting in pramipexole 0.35 mg three times daily, bupropion 150 mg daily, oxazepam 15 mg three times daily, triazolam 0.25 mg daily, and γ-hydroxybutyrate 1.75 g daily.Citation85 A total of 32 cocaine addicts were randomly assigned to the experimental group (rTMS over left DlPfCx) or the control group during 29 days. The rTMS treatment was applied with daily sessions for the first 5 days, and once a week for the following 3 weeks. At the end of stage 1, a 63-day follow-up took place, during which the participants could choose to continue in the same group or switch to the other. During stage 2, participants belonging to control group in stage 1 received the same protocol of stimulation applied in the rTMS experimental group. At the end of stage 1, 16 patients (100%) concluded the treatment in the rTMS group, while 13 patients (81%) concluded the pharmacological treatment in the control group. The authors analyzed the urine drug tests in the two groups at the end of stage 1, finding a higher number of cocaine-free urine samples in the rTMS group. Similar observations were found in the craving VAS, which resulted in significantly lower scores in the experimental group. The ten subjects that switched to the rTMS group in stage 2 displayed significant improvement with favorable outcomes comparable to those of the rTMS group. No differences were found in secondary outcomes. In spite of the open-label design and the use of a variety of pharmacological treatments as a control group, this study provided significant progress in methodological control, since an objective marker of cocaine consumption was used. Another important aspect of the Terraneo et al study is the direct comparison between rTMS-treated patients and pharmacological treatment (as usual) patients.Citation85 Rapinesi et al administered 12 sessions of rTMS through the H-coil to seven cocaine addicts.Citation86 The 12 sessions were applied three times a week alternately during 4 weeks. Bilateral rTMS was delivered at high frequency (15 Hz) and 100% MT in 20 trains with 2 seconds of interstimulus interval for a total of 8,640 pulses (720 pulses/session). They used cocaine craving measured with VAS as an outcome assessed the week before, each week during the treatment and 1 month after rTMS. At the end of the study, the authors found a significant craving reduction from baseline to 2 weeks and 4 weeks and from baseline to 1 month later. Despite there being a significant increase of craving from week 4 to 8, this study provided the first evidence of medium-term effect (baseline to 1 month after treatment) of bilateral rTMS of the PfCx as a whole in cocaine craving. However, the small sample, absence of a control group, and subjective outcome did not allow the authors to make any definitive conclusion. In 2016, we designed a double-blind randomized pilot study to test the efficacy of bilateral deep rTMS in cocaine intake.Citation87 A total of 18 treatment-seeking patients with current CUD according to DSM-IV criteria were recruited and randomly assigned to active 10 Hz stimulation or sham stimulation. A total of 12 sessions of rTMS were administered three times/week (every other day) for 4 weeks at 100% MT over the bilateral PfCx. Each session comprised 20 trains of 50 pulses with 15 seconds of interstimulus interval between trains, for a total of 1,000 pulses per session.Citation88,Citation89 The activation of the sham protocol by a magnetic card reader mimicked the acoustic sounds of the active one without inducing magnetic fields. We considered as outcome the cocaine intake assessed by hair analysis before treatment and at 1, 3, and 6 months later. We decided to use the hair test as a measure of drug intake, because it provides long-term information on drug consumption with higher sensitivity and specificity than urine analysis.Citation90,Citation91 We also monitored the subjects who abandoned the study before the end of treatment (dropouts) and relapses among those patients who completed the protocol. Three subjects from the sham group (37%) and one from the active group (10%) abandoned the study before ending the 12 sessions of stimulation. Two subjects of four (50%) from the sham group relapsed three times after the treatment, while two subjects of six (33%) from the active group reported one relapse after 6 months from onset of treatment. At the end of the study we analyzed the effect of deep rTMS on cocaine intake on ten cocaine addicts over a 6-month period. Between-group analysis indicated no difference on cocaine intake along time; however, the exploratory within-group analysis showed a significant reduction in the amount of cocaine detected from baseline to 3 and 6 months later in the active group and not in the sham one. Notably a lower rate of dropout was observed in the active group compared to the sham. In contrast to previous studies, we tested the effect of TMS in both active and sham groups, finding a profound reduction in cocaine intake in both but no difference in cocaine intake between the two experimental condition, thereby highlighting a strong placebo effect.Citation79,Citation81,Citation85,Citation86 However, the paucity of the sample may have played a role in these results. Moreover, we used as outcome an objective measure of cocaine intake (hair analysis) over 6 months. Cocaine craving was not measured. In 2015, Hanlon et al, starting from a new theoretical model to choose the target area to be stimulated, applied continuous θ-burst stimulation (cTBS) over the medial pre-frontal cortex (MPfCx).Citation92 Unlike classic rTMS, which delivers several trains of consecutive stimuli, cTBS delivers bursts of three pulses at 50 Hz applied at 5 Hz at an amplitude determined by subjective MT. cTBS is expected to induce LTD (whereas intermittent TBS should produce LTP) in a given brain area, and similar effects have been observed in humans by using continuous or intermittent TBS, respec tively.Citation93Citation96 On these bases, Hanlon et al performed a single-blind, sham-controlled, crossover study to test the efficacy of cTBS over MPfCx to modulate craving in cocaine-dependent subjects.Citation92 Craving was evaluated through self-report (score 0–10) three times before and three times after cTBS sessions. They recruited eleven chronic cocaine users, who underwent behavioral assessment and urine drug screens before treatment with TMS–blood-oxygen-level dependent (BOLD) scanning. Then, each subject underwent both real and sham rTMS administered over FP1 (landmark based on an EEG 10–20 system). Subsequently, another TMS/BOLD scan was acquired. To obtain an estimate of LTD induced by cTBS, the researchers compared the evoked BOLD signal after real/sham stimulation to the evoked BOLD signal pre-real/sham cTBS, and the same procedure was applied for craving. The results showed lower TMS-evoked activity in the cortical area near the coil (MPfCx), as well as in projections to arginine vasotocin after real cTBS and a greater reduction than sham cTBS in the Insula, middle temporal gyrus, thalamus, and caudate. Moreover, they found an increase in craving after sham stimulation, but no significant difference in mean scores was found between the two groups.

Despite the small sample, this study offered a new contribution and perspective to the stimulation models implemented, since instead of stimulating the DlPfCx network and amplifying executive cortical control through LTP plasticity, they targeted the MPfCx, in order to attenuate limbic drive circuits through LTD-like plasticity. Further, Hanlon et al reported similar encouraging results on the MPfCx.Citation97

Discussion

In this paper, we reviewed studies that investigated the potential of rTMS in the treatment of cocaine addiction. We reviewed protocols of stimulation delivered, outcomes used, and results observed. Despite CUD representing a word health emergency associated with high relapse rates (short-term relapse rates can reach 75%) significant disability, and substantial mortality, only six studies had explored the effects of TMS in CUD.Citation98 Moreover, there has been no US Food and Drug Administration-approved pharmacotherapy to date, and behavioral approaches to chronic cocaine use have had limited success.

Studies that investigated the therapeutic potential of TMS had generally small samples, were variable in the protocol of stimulation applied, and different in the measurement of outcomes considered. An important issue concerns the study design applied. From this revision of the literature, it emerged that only two studies provided a sham control group, an element that maximizes methodological control, allowing evaluation of the placebo effect so as to derive the real effect of treatment implemented (ie, TMS). In terms of stimulation paradigms, studies differed in both coil employed and parameters adopted. The majority of rTMS studies in CUD have used the figure-of-8 coil to target the DlPfCx (left side), a central node in the frontostriatal network whose functionality is inhibited in addiction disorders.Citation8,Citation9 Cortical dysfunction may account at least in part for the impaired executive control that is required to resist drug-related stimuli and cease drug-seeking behavior. For this reason, papers reviewed here aimed at prefrontal brain regions, in order to enhance cortical activity, improve behavioral control, and through this inhibit drug intake. From a neurobiological perspective, the clinical beneficial effects of TMS over DlPfCx are supported by the evidence, which demonstrated the enhancement of dopaminergic activity in the midbrain (nucleus accumbens), which is depressed in addiction.Citation64,Citation65Citation99 Two studies implemented the H-coil in the treatment of cocaine addiction, finding a significant reduction in craving and intake.Citation86,Citation87 However, only one study considered the sham group, reporting a lasting reduction in cocaine intake, but no difference between the real and the control groups.Citation87 The small sample, however, does not permit any firm conclusion on the efficacy of rTMS in the treatment of cocaine addiction, but results are nevertheless encouraging and foster future investigations. Another study changed the theoretical model by using bursts of pulses (cTBS) over the MPfCx.Citation92 This new model started from the hypothesis that the MPfCx is the primary cortical input to the ventral striatum, a central node in elaborating the salience of drug-related stimuli and the motivation/drive for drug seeking. This hypothesis is supported by a previous study, which demonstrated that LTP-like (10 Hz) rTMS to the MPfCx in a group of eleven healthy non-drug-using subjects was associated with a significant reduction in DA-binding potential in the dorsal striatum, reflecting a release of DA in these areas.Citation98 Despite the small sample, this new approach could provide a novel efficacious strategy to target the areas involved in craving for cocaine, and reiterates the key role played by impoverished DA transmission in these effects.Citation22

The frequency of stimulation observed in the studies revised was 10–20 Hz, with one to 12 sessions. The intensity of stimulation, varied from 90% to 120% of MT. In all studies, the targeted area was identified through scalp landmarks, and only one study used neuronavigation to enhance accuracy in targeting the selected brain region to be stimulated.Citation85,Citation99 The total number of pulses, a key factor in stimulation efficacy, varied and comprised between 600 and 2,400 pulses/session.Citation100Citation102 For these reasons, all studies reviewed implemented a repetitive-stimulation protocol for several sessions, and this is one of the areas that should be investigated further in future studies to achieve long-lasting effects.Citation39 However, none of these studies has been replicated so far and the variability of the stimulation protocol implemented does not allow firm conclusions. Another important factor concerns the measurements of outcome and the follow-up assessment along the timeline. Half the studies used a self-report scale (VAS) as a measurement for craving. This is a construct developed to define and evaluate the desire/drive to take the substance of abuse reported by the addicts, and thereby it is a subjective measure that correlates with clinical effects and relapse rates.Citation31,Citation33 Only two studies of six were objective markers of intake consisting in urine drug tests and hair analysis used. Finally, the timeline of the experimental procedure must be considered.Citation85,Citation87 Most of the studies revised evaluated the TMS effects after treatment, and only one study performed 3- and 6-month follow-up.Citation87 This aspect must be evaluated carefully for short- and long-term effects so as to modulate the protocol and maximize the stimulation effects.

Conclusion

We observed encouraging but preliminary evidence of efficacy of rTMS in treating behavioral and psychological symptoms of cocaine addiction. However, the very small samples and lack of methodological control do not permit identification of a specific protocol of stimulation as superior vs others, although the PfCx appears to be the brain area targeted and with solid neurobiological rationale promises to yield more favorable outcomes in terms of reduction of cocaine intake in future.Citation22,Citation44,Citation92 Further studies are needed, and should employ standard methodological procedures to find the exact location of targeted areas to improve effectiveness of stimulation, consider subjective (craving) and objective (intake) measurements in relation to neurophysiologic substrates to have a comprehensive understanding of the neuropathology, and consider timeline follow-up to evaluate the lasting nature of neural changes induced by rTMS carefully. Overall, rTMS appears ready to be scrutinized with scientific rigor in a condition (ie, CUD) presently bereft of specific pharmacological and efficacious treatment.

Acknowledgments

This work was supported in part through a fundraising campaign organized and conducted by Gieffe Supermercati SRL.

Supplementary material

Table S1 Studies that have used TMS in the treatment of other addiction disorders

Disclosure

The authors report no conflicts of interest in this work.

References

  • European Monitoring Centre for Drugs and Drug AddictionEuropean Drug Report: Trends and DevelopmentsLisbonEMCDDA2017
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edWashingtonAPA2013
  • RossettiZLHmaidanYGessaGLMarked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in ratsEur J Pharmacol19922212272341426002
  • MelisMSpigaSDianaMThe dopamine hypothesis of drug addiction: hypodopaminergic stateInt Rev Neurobiol20056310115415797467
  • KoobGFle MoalMPlasticity of reward neurocircuitry and the ‘dark side’ of drug addictionNat Neurosci200581442144416251985
  • VolkowNDWangGJFowlerJSDecreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjectsNature2007386830833
  • VolkowNDRoyAWBalerRThe dopamine motive system: implications for drug and food addictionNat Rev Neurosci20171874175229142296
  • JentschJDTaylorJRImpulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuliPsychopharmacology (Berl)199914637339010550488
  • GoldsteinRZVolkowNDDysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implicationsNat Rev Neurosci20111265266922011681
  • KoobGFVolkowNNeurocircuitry of addictionNeuropsychopharmacology20103521723819710631
  • VolkowNDrug dependence and addiction, III: expectation and brain function in drug abuseAm J Psychiatry200416162115056504
  • VolkowNDFowlerJSWangGJThe addicted human brain: insights from imaging studiesJ Clin Invest20031111444145112750391
  • KalivasPWBradyKGetting to the core of addiction: hatching the addiction eggNat Med20121850250322481410
  • EverittBJRobbinsTWNeural systems of reinforcement for drug addiction: from actions to habits to compulsionNat Neurosci200581481148916251991
  • ChenJTanZZengLHeterosynaptic long-term depression mediated by ATP released from astrocytesGlia20136117819123044720
  • GoldsteinRZVolkowNDDysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implicationsNat Rev Neurosci20111265266922011681
  • VolkowNDFowlerJSWangGJSwansonJMDopamine in drug abuse and addiction: results from imaging studies and treatment implicationsMol Psychiatry2004955756915098002
  • VolkowNDFowlerJSAddiction a disease of compulsion and drive: involvement of the orbitofrontal cortexCereb Cortex20001031832510731226
  • VolkowNDKoobGFMcLellanATNeurobiologic advances from the brain disease model of addictionN Engl J Med201637436337126816013
  • LondonEDImpulsivity, stimulant abuse and dopamine receptor signalingAdv Pharmacology2016766784
  • LondonEDKohnoMMoralesAMBallardMEChronic methamphetamine abuse and corticostriatal deficits revealed by neuroimagingBrain Res2015162817418525451127
  • DianaMThe dopamine hypothesis of drug addiction and its potential therapeutic valueFront Psychiatry201126422144966
  • LeggioLCardoneSFerrulliATurning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependenceCurr Pharm Des201016215921820482506
  • VolkowNDFowlerJSWangGJBalerRTelangFImaging dopamine’s role in drug abuse and addictionNeuropharmacology2009563818617195
  • DianaMThe addicted brainFront Psychiatry201344023761765
  • KalivasPWThe neural basis of addiction: a pathology of motivation and choiceAm J Psychiatry20051621403141316055761
  • BalerRDVolkowNDDrug addiction: the neurobiology if disrupted self-controlTrends Mol Med20061255956617070107
  • BerridgeKCThe debate over dopamine’s role in reward: the case for incentive saliencePsychopharmacology (Berl)200719139143117072591
  • EverittBJRobbinsTWNeural system of reinforcement for drug addiction: from action to habits to compulsionNat Neurosci200581481148916251991
  • KoobGFle MoalMAddiction and the brain antireward systemAnnu Rev Psychol200859295318154498
  • OslinDWCaryMSlaymakerVColleranCBlowFCDaily ratings measures of alcohol craving during an inpatient stay define subtype of alcohol addiction that predict subsequent risk for resumption of drinkingDrug Alcohol Depend200910313113619443131
  • SinhaRGarciaMOaliwalOKreekMJRounsevillBJStress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapses outcomeArch Gen Psychiatry20066332433116520439
  • JansenJMDaamsJGKoeterMWVeltmanDJvan den BrinkWGoudriaanAEEffects of non-invasive neurostimulation on craving: a meta-analysisNeurosci Biobehav Rev2013372472248023916527
  • FattoreLDianaMDrug addiction: an affective-cognitive disorder in need of a cureNeurosci Biobehav Rev20166534136127095547
  • GaravanHHThe role of cognitive control in cocaine dependenceNeuropsychol Rev20071733734517680368
  • van HolstRJSchiltTDrug-related decrease in neuropsychological functions of abstinent drug usersCurr Drug Abuse Rev20114425621466500
  • BackSEHartwellKDeSantisSMReactivity to laboratory stress provocation predicts relapse to cocaineDrug Alcohol Depend2010106212719726138
  • PolingJKostenTRSofuogluMTreatment outcome predictors for cocaine dependenceAm J Drug Alcohol Abuse20073319120617497542
  • FeilJZangenABrain stimulation in the study and treatment of addictionNeurosci Biobehav Rev20103455957419914283
  • SundaresanKZiemannUStan-LeyJBoutrosNCortical inhibition and excitation in abstinent cocaine-dependent patients: a transcranial magnetic stimulation studyNeuroreport20071828929217314673
  • BarkerAJalinousRFreestonINon-invasive magnetic stimulation of human motor cortexLancet19851110611072860322
  • Di LazzaroVZiemannULemonRState of the art: physiology of transcranial motor cortex stimulationBrain Stimul2008134536220633393
  • GorelickDAZangenAGeorgeMSTranscranial magnetic stimulation in the treatment of substance addictionAnn N Y Acad Sci20141327799325069523
  • DianaMRaijTMelisMNummenmaaALeggioLBonciARehabilitating the addicted brain with transcranial magnetic stimulationNat Rev Neurosci20171868569328951609
  • LisanbySHHusainMMRosenquistPBDaily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trialNeuropsychopharmacology20093452253418704101
  • BenadhiraRThomasFBouazizNA randomized, sham- controlled study of maintenance rTMS for treatment-resistant depression (TRD)Psychiatry Res201725822623328844559
  • FitzgeraldPBHoyKEHerringSEA double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depressionJ Affect Disord201213919319822397890
  • AlonsoPPujolJCardonerNRight prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled studyAm J Psychiatry20011581143114511431238
  • LeeSHKimWChungYCA double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinationsNeurosci Lett200537617718115721217
  • JinYPotkinSGKempASTherapeutic effects of individualized alpha frequency transcranial magnetic stimulation (αTMS) on the negative symptoms of schizophreniaSchizophr Bull20053255656116254067
  • RossiSHallettMRossiniPMPascual-LeoneASafety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and researchClin Neurophysiol20091202008203919833552
  • PausTJechRThompsonCJTranscranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortexJ Neurosci199717317831849096152
  • IlmoniemiRJVirtanenJRuohonenJNeuronal responses to magnetic stimulation reveal cortical reactivity and connectivityNeuroreport19978353735409427322
  • TeraoYUgawaYBasic mechanisms of TMSJ Clin Neurophysiol20021932234312436088
  • RothYAmirALevkovitzYZangenAThree-dimensional distribution of the electric field induced in the brain by TMS using figure-8 and deep H-coilsJ Clin Neurophysiol200724313817277575
  • HoogendamJRamakersGDi LazzaroVPhysiology of repetitive transcranial magnetic stimulation of the human brainBrain Stimul201039511820633438
  • CeccantiMInghilleriMAttiliaMLDeep TMS on alcoholics: effects on cortisolemia and dopamine pathway modulation – a pilot studyCan J Physiol Pharmacol20159328329025730614
  • MishraBRNizamieSHDasBPraharajSKEfficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled studyAddiction2010105495520078462
  • AzevedoCAMammisAMNeuromodulation therapies for alcohol addiction: a literature reviewNeuromodulation20182114414828055126
  • AmiazRLevyDVainigerDGrunhausLZangenARepeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumptionAddiction200910465366019183128
  • Dinur-KleinLDannonPHadarASmoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trialBiol Psychiatry20147674274925038985
  • LiXMalcolmRJHuebnerKLow frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary studyDrug Alcohol Depend201313364164624028801
  • ShenYCaoXTanT10-Hz repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex reduces heroin cue craving in long-term addictsBiol Psychiatry201680e13e1426995024
  • MakaniRPradhanBShahUParikhTRole of repetitive transcranial magnetic stimulation (rTMS) in treatment of addiction and related disorders: a systematic reviewCurr Drug Abuse Rev Epub20171129
  • SpagnoloPAGoldmanDNeuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future researchBrain20171401183120328082299
  • StrafellaAPPausTBarrettJDagherARepetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleusJ Neurosci200121RC157
  • ChoSStrafellaArTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortexPLoS One20094e672519696930
  • GoldsteinRZLeskovjanACHoffALSeverity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortexNeuropsychologia2004421447145815246283
  • RothYZangenAHallettMA coil design for transcranial magnetic stimulation of deep brain regionsJ Clin Neurophysiol20021936137012436090
  • RothYZangenAVollerBHallettMTranscranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coilClin Neurophysiol200511677577915792886
  • RothYPellGSChistyakovAVSinaiAZangenAZaaroorMMotor cortex activation by H-coil and figure-8 coil at different depths: combined motor threshold and electric field distribution studyClin Neurophysiol201412533634323994191
  • NummenmaaAStenroosMIlmoniemiRJOkadaYCHämäläinenMSRaijTComparison of spherical and anatomically realistic boundary element models for transcranial magnetic stimulation navigationClin Neurophysiol20131241995200723890512
  • DengZLisanbySPeterchevAElectric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designsBrain Stimul2013611322483681
  • RossiniPMBurkeDChenRNon-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application – an updated report from an I.F.C.N. CommitteeClin Neurophysiol20151261071110725797650
  • ZangenARothYVollerBHallettMTranscranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coilClin Neurophysiol200511677577915792886
  • MalikSJacobsMChoSSDeep TMS of the insula using the H-coil modulates dopamine release: a crossover [11C] PHNO-PET pilot trial in healthy humansBrain Imaging Behav Epub20171123
  • SallingMCMartinezDBrain stimulation in addictionNeuropsychopharmacology2016412798280927240657
  • RuohonenJKarhuJNavigated transcranial magnetic stimulationNeurophysiol Clin20104071720230931
  • CamprodonJAMartinez-RagaJAlonso-AlonsoMShihMCPascual-LeoneAOne session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine cravingDrug Alcohol Depend200786919416971058
  • RobertsonEMTheoretHPascual-LeoneAStudies in cognition: the problems solved and created by transcranial magnetic stimulationJ Cogn Neurosci20031594896014614806
  • PolitiEFauciESantoroASmeraldiEDaily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine cravingAm J Addict20081734534618612892
  • MaasLCLukasSEKaufmanMJFunctional magnetic resonance imaging of human brain activation during cue-induced cocaine cravingAm J Psychiatry19981551241269433350
  • GaravanHPankiewiczJBloomACue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuliAm J Psychiatry20001571789179811058476
  • BonsonKRGrantSJContoreggiCSNeural systems and cue induced cocaine cravingNeuropsychopharmacology20022637638611850152
  • TerraneoALeggioLSaladiniMErmaniMBonciAGallimbertiLTranscranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: a pilot studyEur Neuropsychopharmacol201626374426655188
  • RapinesiCdel CasaleADi PietroSAdd-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex reduces cocaine craving in patients with cocaine use disorderNeurosci Lett2016629434727365134
  • BolloniCPanellaRPedettiMBilateral transcranial magnetic stimulation of the prefrontal cortex reduces cocaine intake: a pilot studyFront Psychiatry2016713327551268
  • LevkovitzYHarelEVRothYDeep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patientsBrain Stimul2009218820020633419
  • LevkovitzYIsserlessMPadbergFEfficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trialWorld Psychiatry201514647325655160
  • UrsittiFKleinJSellersEKorenGUse of hair analysis for confirmation of self-reported cocaine use in users with negative urineJ Toxicol Clin Toxicol20013936136611527230
  • DuPontRLBaumgartnerWADrug testing by urine and hair analysis: complementary features and scientific issueForensic Sci Int19957063767860037
  • HanlonCADowdleLTAustelleCWWhat goes up, can come down: novel brain stimulation paradigms may attenuate craving and craving related neural circuitry in substance dependent individualsBrain Res2015162819920925770818
  • BearMFMalenkaRCSynaptic plasticity: LTP and LTDCurr Opin Neurobiol199443893997919934
  • MalenkaRCBearMFLTP and LTD: an embarrassment of richesNeuron20044452115450156
  • HuangYZEdwardsMJRounisEBhatiaKPRothwellJCTheta-burst stimulation of the human motor cortexNeuron20054520120615664172
  • Di LazzaroVPilatoFSaturnoETheta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortexJ Physiol200556594595015845575
  • HanlonCADowdleLTMossHCanterberryMGeorgeMSMobilization of medial and lateral frontal-striatal circuits in cocaine users and controls: an interleaved TMS/BOLD functional connectivity studyNeuropsychopharmacol20164130323041
  • SinhaRNew findings on biological factors predicting addiction relapse vulnerabilityCurr Psychiatry Rep20111339840521792580
  • WingVCBarrMSWassCEBrain stimulation methods to treat tobacco addictionBrain Stimul2013622123022809824
  • ChoSSKoshimoriYAminianKInvesting in the future: stimulation of the medial prefrontal cortex reduces discounting of delayed rewardsNeuropsychopharmacology20154054655325168685
  • FitzgeraldPBHoyKMcQueenSMallerJJHerringSSegraveRA randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depressionNeuropsychopharmacology2009341255126219145228
  • GershonAADannonPNGrunhausLTranscranial magnetic stimulation in the treatment of depressionAm J Psychiatry200316083584512727683
  • JohannMWiegandRKharrazATranscranial magnetic stimulation for nicotine dependencePsychiatr Prax200330S129S131 German14509058
  • LiXHartwellKJOwensMRepetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue cravingBiol Psychiatry20137371472023485014
  • EichhammerPJohannMKharrazAHigh-frequency repetitive transcranial magnetic stimulation decreases cigarette smokingJ Clin Psychiatry20036495195312927012
  • PripflJTomovaLRiecanskyILammCTranscranial magnetic stimulation of the left dorsolateral prefrontal cortex decreases cue-induced nicotine craving and EEG delta powerBrain Stimul2014722623324468092
  • HayashiTKoJHStrafellaAPDagherADorsolateral prefrontal and orbitofrontal cortex interactions during self-control of cigarette cravingProc Natl Acad Sci U S A20131104422442723359677
  • RoseJEMcClernonFJFroeligerBBehmFMPreud’hommeXKrystalADRepetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettesBiol Psychiatry20117079479921762878
  • WingVCBacherIWuBSDaskalakisZJGeorgeTPHigh frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophreniaSchizophr Res201213926426622464727
  • PrikrylRUstohalLKucerovaHPRepetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patientsProg Neuropsychopharmacol Biol Psychiatry201449303524211840
  • TrojakBMeilleVAchabSTranscranial magnetic stimulation combined with nicotine replacement therapy for smoking cessation: a randomized controlled trialBrain Stimul201581168117426590478
  • AddoloratoGAntonelliMCocciolilloFDeep transcranial magnetic stimulation of the dorsolateral prefrontal cortex in alcohol use disorder patients: effects on dopamine transporter availability and alcohol intakeEur Neuropsychopharmacol2017279450461
  • MishraBRPraharajSKKatshuMZSarkarSNizamieSHComparison of anticraving efficacy of right and left repetitive transcranial magnetic stimulation in alcohol dependence: a randomized double-blind studyJ Neuropsychiatry Clin Neurosci201527e54e5925255169
  • HerremansSCBaekenCVanderbruggenNNo influence of one right sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic studyDrug Alcohol Depend201212020921321855234
  • HerremansSCVanderhasseltMAde RaedtRBaekenCReduced intra-individual reaction time variability during a Go-NoGo task in detoxified alcohol-dependent patients after one right-sided dorsolateral prefrontal HF-rTMS sessionAlcohol Alcohol20134855255723709633
  • HerremansSCvan SchuerbeekPde RaedtRThe impact of accelerated right prefrontal high-frequency repetitive transcranial magnetic stimulation (rTMS) on cue-reactivity: an fMRI study on craving in recently detoxified alcohol-dependent patientsPLoS One201510e013618226295336
  • HöppnerJBroeseTWendlerLBergerCThomeJRepetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependenceWorld J Biol Psychiatry2011125762
  • del FeliceABellamoliEFormaggioENeurophysiological, psychological and behavioural correlates of rTMS treatment in alcohol dependenceDrug Alcohol Depend201615814715326679060
  • SuHZhongNGanHHigh frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex for methamphetamine use disorders: a randomised clinical trialDrug Alcohol Depend2017175849128410525